You have 9 free searches left this month | for more free features.

Advanced Solid Tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial (QL1706H)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 18, 2023

NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Oct 5, 2023

Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Nov 9, 2023

Advanced Solid Cancer Trial (ORB-011)

Not yet recruiting
  • Advanced Solid Cancer
  • (no location specified)
Jul 14, 2023

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Advanced Solid Tumors Trial (SHR-1826)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 16, 2023

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor

Not yet recruiting
  • HER2-expressing Advanced Solid Tumors
  • SHR-A1811 combined with Pyrotinib.
  • SHR-A1811 combined with other antitumor therapies
  • (no location specified)
Aug 28, 2023

Advanced Solid Tumors Trial in Hangzhou (ZGGS15)

Not yet recruiting
  • Advanced Solid Tumors
  • ZGGS15
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 17, 2023

Advanced Solid Tumors Trial (INCB099280, axitinib)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 18, 2023

Advanced Solid Tumors Trial (ASKG915)

Not yet recruiting
  • Advanced Solid Tumors
  • ASKG915
  • (no location specified)
May 10, 2023

Advanced Solid Tumors Trial in Guangzhou (MR001)

Not yet recruiting
  • Advanced Solid Tumors
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Nov 12, 2023

Advanced Solid Tumor Trial (HS-20105)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Nov 17, 2023

Advanced Solid Tumors Trial (RO7589831)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Aug 16, 2023

Advanced Solid Tumors Trial (SHR-7367)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Feb 13, 2023

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Advanced Solid Tumors Trial (SKB410 for injection)

Not yet recruiting
  • Advanced Solid Tumors
  • SKB410 for injection
  • (no location specified)
Jun 13, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
May 12, 2023

GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)

Recruiting
  • GT316,Solid Tumors,Adult
  • GT316
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 16, 2023

Advanced Solid Tumors Trial (VVD-130037)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 12, 2023

HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)

Recruiting
  • HER2-positive Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 10, 2023

Advanced Solid Tumors Trial (QLP2117)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Apr 24, 2023

Advanced Solid Tumors Trial in Jinan, Shanghai (PM1003 Injection)

Recruiting
  • Advanced Solid Tumors
  • PM1003 Injection
  • Jinan, Shandong, China
  • +1 more
May 8, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

Advanced Solid Tumor Trial in Guangzhou (YL-17231)

Recruiting
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 5, 2023